Developer docs
API playgroundTry for free, no card

Search company profiles

Vapotherm

Full company profile

uuid0004n68

Namestring
Vapotherm
Legal namestring
Vapotherm, Inc.
Websiteurl
vapotherm.com
Company typeenum
Private
Founded yearint
1999
Descriptiontext

Vapotherm is specializing in the development, manufacture, and marketing of respiratory devices that improve clinical outcomes, reduce overall delivery costs, and improve quality of life for patients. The company's breakthrough technology centers on the benefits of high flow delivery of breathing gases through a patented process for heating and humidification. Vapotherm high velocity therapy has been shown to provide proven, comfortable respiratory support without the use of a mask. High Velocity Therapy is a method of rethinking ventilatory support while keeping patient comfort and compliance in mind.

Short descriptiontext

Vapotherm is a medical device company that develops a mask-free respiratory support tool.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersExeter, United States
HQ citystring
Exeter
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
respiratory therapy devices, high flow nasal cannula, mask-free ventilation, medical device manufacturing, neonatal respiratory care
Industry5 codes
PRIMARYHLAHAGAG
Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAHAGAC
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAHAGAE
Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAKANAM
Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management
SECONDARYHLAHAGAK
Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Respiratory Care Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Capital Equipment Sales
TypeHardware Sales
Description

Sale of HVT 2.0 systems and Precision Flow systems as capital medical equipment to hospitals and healthcare facilities.

vapotherm.com
2Disposable Accessories
TypeHardware Sales
Description

Recurring revenue from disposable patient circuits, nasal cannulas (ProSoft, Unicorn), tracheostomy adapters, aerosol delivery adapters, and nitric oxide disposable circuits.

vapotherm.com
3VapoCare Service Plans
TypeSubscription Recurring
Description

Comprehensive service and software upgrade plans for up to 5 years, including annual software upgrades, expedited service turnaround, and predictable low service costs.

vapotherm.com
4Ventilator Solutions
TypeHardware Sales
Description

Revenue from VentO2ux ventilator system through partnership with Flight Medical.

vapotherm.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure
Pricing details1 tier
1VapoCare Service Plan for HVT 2.0
ModelSubscriptionBilling cadenceAnnual
Notes

Comprehensive service including all-inclusive service by Vapotherm trained technicians, annual software upgrades, expedited turnaround, and predictable service costs for up to 5 years. Flexible purchasing - pay upfront or billed annually.

vapotherm.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 6 records shown
1HVT 2.0
Description

Next generation high velocity therapy system for mask-free respiratory support

vapotherm.com
+5 more records
Core offering1 text field

Vapotherm designs, manufactures, and sells proprietary high velocity therapy (HVT) respiratory support systems and related disposable accessories for hospitals. Its flagship HVT 2.0 and Precision Flow platforms deliver mask-free, non-invasive ventilatory support that is clinically proven non-inferior to NiPPV, complemented by single-use cannulas, the All Patient Circuit spanning neonatal to adult flow ranges, and the VentO2ux ventilator distributed in partnership with Flight Medical. Recurring revenue is generated through disposable circuits, nasal cannulas, and the multi-year VapoCare service and software upgrade plan.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • COPD patients on high velocity therapy spent less time in ICU compared to COPD patients on NiPPV
+5 more records
Product overview1 text field

Vapotherm offers a comprehensive respiratory therapy portfolio centered on its proprietary high velocity therapy technology. The core product lines include the HVT 2.0 (next-generation system) and Precision Flow System (including Precision Flow Heliox variant), both delivering mask-free non-invasive respiratory support for spontaneously breathing patients. Capital accessories encompass the Oxygen Assist Module for automated oxygen control and the Vapotherm Transfer Unit for patient mobility. The disposable accessories portfolio includes ProSoft Nasal Cannulas, ProSoft Unicorn Cannulas (single-prong), aerosolized medication delivery systems, Nitric Oxide Disposable Patient Circuits, Tracheostomy Adapters, and the FDA-cleared All Patient Circuit (APC) for neonatal-to-adult use. Through partnership with Flight Medical, Vapotherm has expanded to include the VentO2ux Ventilator for ICU and emergency care. The company also offers the VapoCare Service Plan for comprehensive device support.

Product and service13 records
1HVT 2.0 System
CategoryRespiratory therapy capital equipment
Description

Next-generation high velocity therapy system providing mask-free non-invasive respiratory support. Features integrated blower, touchscreen interface, disposable patient circuit, and mobility capabilities for adult, pediatric, and neonatal patients. Designed for hospitals to deliver ventilatory support clinically proven non-inferior to NiPPV.

2Precision Flow System
CategoryRespiratory therapy capital equipment
Description

High velocity therapy system offering precise control of flow, oxygen, and temperature with optimal humidity. Patient-ready in minutes with portable options via Vapotherm Transfer Unit; can be disinfected in less than 10 minutes with disposable circuits usable up to 30 days. Supports EMR and nurse call integration.

3Precision Flow Heliox
4Oxygen Assist Module (OAM)
5Vapotherm Transfer Unit (VTU)
6ProSoft Nasal Cannulas
7ProSoft Unicorn Cannula
CategoryDisposable accessory
Description

Single-prong high velocity therapy cannula designed to enhance CO2 clearance and patient comfort, providing comparable efficacy at lower flow rates compared to traditional dual-prong cannulas.

8Aerosolized Medication Delivery
9Nitric Oxide Disposable Patient Circuit
10Tracheostomy Adapter
11VentO2ux Ventilator
CategoryRespiratory therapy capital equipment
Description

ICU and emergency care ventilator developed through partnership with Flight Medical Innovations Ltd., designed for portability, reliability, and ease of use in US hospitals.

12All Patient Circuit (APC)
CategoryDisposable accessory
Description

FDA 510(k) cleared single disposable patient circuit enabling HVT 2.0 high velocity therapy across a 2-45 L/min flow range for neonatal to adult patients, eliminating the need to change circuits as patient needs evolve.

13VapoCare Service Plan
Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
1Flight Medical Innovations Ltd.
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-12-08
Description

Strategic partnership to bring the VentO2ux ventilator to US hospitals. The collaboration expands Vapotherm's portfolio beyond high velocity therapy devices to a broader platform of respiratory support solutions spanning the continuum of care. The ventilator is designed for ICU and emergency care, focusing on portability, reliability, and ease of use.

prnewswire.com
2International Distributors (Various)
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Global network of regional distributors across 40+ countries including: JAEJ (Argentina), Linde entities (Colombia, Costa Rica, Uruguay, Panama), White Martins (Brazil), Canadian Hospital Specialties (Canada), Eurocare (France), ACP Electromedicina (Spain), Burke & Burke (Italy), Dartin (Slovakia, Czech Republic), Dutchmed (Poland, Romania, Bulgaria), medi-lan Schweiz (Switzerland), HABEL Medizintechnik (Austria), Vapotherm Deutschland GmbH (Germany, Belgium, Spain), Vapotherm UK, Nowus Healthcare (Denmark, Norway, Sweden), Space Equipamentos (Portugal), Sword Medical (Ireland), and distributors across Asia, Africa, and Oceania.

vapotherm.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Fisher & Paykel Healthcare
TypeDirect peer
Description

Fisher & Paykel Healthcare is a leading global manufacturer of respiratory care products, including high flow nasal cannula systems (Optiflow) and humidification products, directly competing with Vapotherm's HVT 2.0 and Precision Flow platforms in hospitals worldwide.

2Philips Respironics
TypeBroad incumbent
Description

Philips Respironics offers a comprehensive respiratory care portfolio spanning hospital NIV, CPAP/BiPAP, and oxygen therapy, providing direct competition to Vapotherm's HVT systems within the same hospital respiratory therapy workflows.

3ResMed
TypeBroad incumbent
Description

ResMed is a global leader in respiratory care with dominant positions in CPAP/BiPAP and a growing footprint in hospital NIV and connected health, competing with Vapotherm across acute and chronic respiratory support.

4Hamilton Medical
TypeDirect peer
Description

Hamilton Medical specializes in ICU and transport mechanical ventilators, directly competing with Vapotherm's VentO2ux ventilator offering and overlapping with Vapotherm's broader respiratory support positioning in ICUs.

5Getinge
TypeBroad incumbent
Description

Getinge provides a broad portfolio of ICU ventilation, anesthesia, and respiratory care solutions through its Maquet and other brands, competing with Vapotherm across acute hospital respiratory therapy and ventilator markets.

6Drägerwerk
TypeBroad incumbent
Description

Dräger is a major medical and safety technology company offering ICU ventilators, anesthesia delivery, and patient monitoring, directly competing with Vapotherm's ventilator and respiratory care products in hospital settings.

7BMC Medical
TypeEmerging player
Description

BMC Medical is a Chinese respiratory device manufacturer with HFNC, NIV, and ventilator products that overlap with Vapotherm's HVT portfolio, particularly in Asia-Pacific and emerging markets.

8Inspire Medical Systems
TypeEmerging player
Description

Inspire Medical Systems focuses on obstructive sleep apnea and respiratory sleep therapy, with adjacent clinical positioning to Vapotherm's mask-free NIV work in sleep-disordered breathing and chronic respiratory care.

9Inogen
TypeEmerging player
Description

Inogen specializes in portable oxygen concentrators and respiratory equipment for home and ambulatory use, adjacent to Vapotherm's COPD and home ventilation focus with the Access365 Home Ventilation Solution.

10Masimo
TypeOthers
Description

Masimo is a leading patient monitoring and pulse oximetry company whose products are routinely used alongside Vapotherm's HVT systems in hospital respiratory care, making it a complementary ecosystem participant rather than a direct competitor.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers7 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment6 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration2 records

Each record includes

Title, Type, Description, Source

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles18 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds15 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors16 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Vapotherm

Respiratory Care Medical Devicesvapotherm.com

Vapotherm is a medical device company that develops a mask-free respiratory support tool.

What Vapotherm does

Vapotherm is specializing in the development, manufacture, and marketing of respiratory devices that improve clinical outcomes, reduce overall delivery costs, and improve quality of life for patients. The company's breakthrough technology centers on the benefits of high flow delivery of breathing gases through a patented process for heating and humidification. Vapotherm high velocity therapy has been shown to provide proven, comfortable respiratory support without the use of a mask. High Velocity Therapy is a method of rethinking ventilatory support while keeping patient comfort and compliance in mind.

Vapotherm firmographics

Firmographics
Name
Vapotherm
Legal name
Vapotherm, Inc.
Website
https://vapotherm.com
Company type
Private
Founded year
1999
Operating status
Operating
Headcount range
251–500 employees
Short description
Vapotherm is a medical device company that develops a mask-free respiratory support tool.
Ownership category
akta.pro rank

Vapotherm industry classification

Industry
Product category
Respiratory Care Medical Devices
SIC
Surgical & Medical Instruments & Apparatus (3841)
akta.pro industry
PRIMARYHLAHAGAG
Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAHAGAC
Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAHAGAE
Inhalation & Nebulization Devices (Nebulizers, Spacers, Inhaler Accessories)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices
SECONDARYHLAKANAM
Home Ventilation, Oxygen Therapy & Respiratory DME Clinical Management
SECONDARYHLAHAGAK
Anesthesia & Respiratory Gas Delivery Equipment (Breathing Circuits, Vaporizers, Gas Mixers)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Respiratory & Sleep Therapy Devices

Keywords

  • Respiratory therapy devices
  • High flow nasal cannula
  • Mask-free ventilation
  • Medical device manufacturing
  • Neonatal respiratory care

Where Vapotherm is headquartered

Location

Headquarters

HQ city
Exeter
HQ country
United States
HQ region
North America

Offices3 records

Markets served

Vapotherm business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

  1. Capital Equipment Sales: Sale of HVT 2.0 systems and Precision Flow systems as capital medical equipment to hospitals and healthcare facilities.
  2. Disposable Accessories: Recurring revenue from disposable patient circuits, nasal cannulas (ProSoft, Unicorn), tracheostomy adapters, aerosol delivery adapters, and nitric oxide disposable circuits.
  3. VapoCare Service Plans: Comprehensive service and software upgrade plans for up to 5 years, including annual software upgrades, expedited service turnaround, and predictable low service costs.
  4. Ventilator Solutions: Revenue from VentO2ux ventilator system through partnership with Flight Medical.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualVapoCare Service Plan for HVT 2.0

Go-to-market motion1 record

Distribution channels2 records

Marketing channels8 records

Vapotherm product offering

Product offering

Core offering

Vapotherm designs, manufactures, and sells proprietary high velocity therapy (HVT) respiratory support systems and related disposable accessories for hospitals. Its flagship HVT 2.0 and Precision Flow platforms deliver mask-free, non-invasive ventilatory support that is clinically proven non-inferior to NiPPV, complemented by single-use cannulas, the All Patient Circuit spanning neonatal to adult flow ranges, and the VentO2ux ventilator distributed in partnership with Flight Medical. Recurring revenue is generated through disposable circuits, nasal cannulas, and the multi-year VapoCare service and software upgrade plan.

Product overview

Vapotherm offers a comprehensive respiratory therapy portfolio centered on its proprietary high velocity therapy technology. The core product lines include the HVT 2.0 (next-generation system) and Precision Flow System (including Precision Flow Heliox variant), both delivering mask-free non-invasive respiratory support for spontaneously breathing patients. Capital accessories encompass the Oxygen Assist Module for automated oxygen control and the Vapotherm Transfer Unit for patient mobility. The disposable accessories portfolio includes ProSoft Nasal Cannulas, ProSoft Unicorn Cannulas (single-prong), aerosolized medication delivery systems, Nitric Oxide Disposable Patient Circuits, Tracheostomy Adapters, and the FDA-cleared All Patient Circuit (APC) for neonatal-to-adult use. Through partnership with Flight Medical, Vapotherm has expanded to include the VentO2ux Ventilator for ICU and emergency care. The company also offers the VapoCare Service Plan for comprehensive device support.

Differentiator

Problem solved

Functional benefit

Brands

  • HVT 2.0: Next generation high velocity therapy system for mask-free respiratory support
  • Precision Flow
  • ProSoft
  • UNICORN Cannula
  • VentO2ux
  • VapoCare

Products and services

  • HVT 2.0 System Next-generation high velocity therapy system providing mask-free non-invasive respiratory support. Features integrated blower, touchscreen interface, disposable patient circuit, and mobility capabilities for adult, pediatric, and neonatal patients. Designed for hospitals to deliver ventilatory support clinically proven non-inferior to NiPPV.
  • Precision Flow System High velocity therapy system offering precise control of flow, oxygen, and temperature with optimal humidity. Patient-ready in minutes with portable options via Vapotherm Transfer Unit; can be disinfected in less than 10 minutes with disposable circuits usable up to 30 days. Supports EMR and nurse call integration.
  • Precision Flow Heliox
  • Oxygen Assist Module (OAM)
  • Vapotherm Transfer Unit (VTU)
  • ProSoft Nasal Cannulas
  • ProSoft Unicorn Cannula Single-prong high velocity therapy cannula designed to enhance CO2 clearance and patient comfort, providing comparable efficacy at lower flow rates compared to traditional dual-prong cannulas.
  • Aerosolized Medication Delivery
  • Nitric Oxide Disposable Patient Circuit
  • Tracheostomy Adapter
  • VentO2ux Ventilator ICU and emergency care ventilator developed through partnership with Flight Medical Innovations Ltd., designed for portability, reliability, and ease of use in US hospitals.
  • All Patient Circuit (APC) FDA 510(k) cleared single disposable patient circuit enabling HVT 2.0 high velocity therapy across a 2-45 L/min flow range for neonatal to adult patients, eliminating the need to change circuits as patient needs evolve.
  • VapoCare Service Plan

Quantifiable outcome

  • COPD patients on high velocity therapy spent less time in ICU compared to COPD patients on NiPPV
  • +5 more outcomes

Companies that use Vapotherm

Customer profile

Named customers7 records

Segments6 records

Ideal customer profiles4 records

Vapotherm technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration2 records

Feature7 records

Vapotherm partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Flight Medical Innovations Ltd.coreStrategic or Co-development Partner · 8 December 2025Strategic partnership to bring the VentO2ux ventilator to US hospitals. The collaboration expands Vapotherm's portfolio beyond high velocity therapy devices to a broader platform of respiratory support solutions spanning the continuum of care. The ventilator is designed for ICU and emergency care, focusing on portability, reliability, and ease of use.
  • International Distributors (Various)coreChannel Partner/ Reseller/ DistributorGlobal network of regional distributors across 40+ countries including: JAEJ (Argentina), Linde entities (Colombia, Costa Rica, Uruguay, Panama), White Martins (Brazil), Canadian Hospital Specialties (Canada), Eurocare (France), ACP Electromedicina (Spain), Burke & Burke (Italy), Dartin (Slovakia, Czech Republic), Dutchmed (Poland, Romania, Bulgaria), medi-lan Schweiz (Switzerland), HABEL Medizintechnik (Austria), Vapotherm Deutschland GmbH (Germany, Belgium, Spain), Vapotherm UK, Nowus Healthcare (Denmark, Norway, Sweden), Space Equipamentos (Portugal), Sword Medical (Ireland), and distributors across Asia, Africa, and Oceania.

Scale indicators8 records

Recent moves7 records

Expansion highlights5 records

Vapotherm competitors and assessment

Company assessment

Direct peers

  • Fisher & Paykel Healthcare: Fisher & Paykel Healthcare is a leading global manufacturer of respiratory care products, including high flow nasal cannula systems (Optiflow) and humidification products, directly competing with Vapotherm's HVT 2.0 and Precision Flow platforms in hospitals worldwide.
  • Hamilton Medical: Hamilton Medical specializes in ICU and transport mechanical ventilators, directly competing with Vapotherm's VentO2ux ventilator offering and overlapping with Vapotherm's broader respiratory support positioning in ICUs.

Broad incumbents

  • Philips Respironics: Philips Respironics offers a comprehensive respiratory care portfolio spanning hospital NIV, CPAP/BiPAP, and oxygen therapy, providing direct competition to Vapotherm's HVT systems within the same hospital respiratory therapy workflows.
  • ResMed: ResMed is a global leader in respiratory care with dominant positions in CPAP/BiPAP and a growing footprint in hospital NIV and connected health, competing with Vapotherm across acute and chronic respiratory support.
  • Getinge: Getinge provides a broad portfolio of ICU ventilation, anesthesia, and respiratory care solutions through its Maquet and other brands, competing with Vapotherm across acute hospital respiratory therapy and ventilator markets.
  • Drägerwerk: Dräger is a major medical and safety technology company offering ICU ventilators, anesthesia delivery, and patient monitoring, directly competing with Vapotherm's ventilator and respiratory care products in hospital settings.

Emerging players

  • BMC Medical: BMC Medical is a Chinese respiratory device manufacturer with HFNC, NIV, and ventilator products that overlap with Vapotherm's HVT portfolio, particularly in Asia-Pacific and emerging markets.
  • Inspire Medical Systems: Inspire Medical Systems focuses on obstructive sleep apnea and respiratory sleep therapy, with adjacent clinical positioning to Vapotherm's mask-free NIV work in sleep-disordered breathing and chronic respiratory care.
  • Inogen: Inogen specializes in portable oxygen concentrators and respiratory equipment for home and ambulatory use, adjacent to Vapotherm's COPD and home ventilation focus with the Access365 Home Ventilation Solution.

Others

  • Masimo: Masimo is a leading patient monitoring and pulse oximetry company whose products are routinely used alongside Vapotherm's HVT systems in hospital respiratory care, making it a complementary ecosystem participant rather than a direct competitor.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Vapotherm social profiles

Digital presence

Vapotherm compliance and trust

Trust signal

Compliance3 records

Vapotherm financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Vapotherm leadership team

Management profile

Number of profiles

Profiles18 records

Vapotherm subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

Vapotherm funding detail

Funding detail

Funding overview

Funding rounds15 records

Investors16 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Vapotherm M&A and investment

M&A and investment

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Vapotherm

What does Vapotherm do?

Vapotherm designs, manufactures, and sells proprietary high velocity therapy (HVT) respiratory support systems and related disposable accessories for hospitals. Its flagship HVT 2.0 and Precision Flow platforms deliver mask-free, non-invasive ventilatory support that is clinically proven non-inferior to NiPPV, complemented by single-use cannulas, the All Patient Circuit spanning neonatal to adult flow ranges, and the VentO2ux ventilator distributed in partnership with Flight Medical. Recurring revenue is generated through disposable circuits, nasal cannulas, and the multi-year VapoCare service and software upgrade plan.

Is Vapotherm a public or private company?

Vapotherm is a private company. It is classified as private equity controlled and is currently operating.

When was Vapotherm founded?

Vapotherm was founded in 1999. It employs 251 to 500 people.

Where is Vapotherm based?

Vapotherm is headquartered in Exeter, United States, in the North America region.

How does Vapotherm make money?

Four revenue lines are on record. Capital Equipment Sales are the primary driver. The others are disposable Accessories, vapoCare Service Plans and ventilator Solutions.

Who are Vapotherm's main competitors?

Direct peers on record are Fisher & Paykel Healthcare and Hamilton Medical. Broad incumbents are Philips Respironics, ResMed, Getinge and Drägerwerk. Emerging players are BMC Medical, Inspire Medical Systems and Inogen. Masimo is listed as an others.

Does Vapotherm have an API?

No public API is recorded for Vapotherm.

What industry is Vapotherm in?

Vapotherm's product category is Respiratory Care Medical Devices. Its primary akta.pro industry code is HLAHAGAG, Noninvasive Ventilation Interfaces & Consumables (Masks, Tubing, Humidifiers, Filters), with a secondary code of HLAHAGAC, Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home). Its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireVapotherm® Announces FDA 510(k) Clearance for the All Patient Circuit™, Enabling High Velocity Therapy for Neonatal to Adult PatientsVapotherm, Inc. announced FDA 510(k) clearance for its All Patient Circuit (APC), which expands the HVT 2.0 high velocity therapy system to treat neonatal and infant patients in addition to adults. The single disposable circuit covers a 2–45 L/min flow range and is designed to reduce clinical complexity by eliminating the need to change circuits as patient needs evolve. This regulatory clearance enables the company to support a broader patient population with one circuit, simplifying workflows across Emergency, ICU, and other hospital settings.PR NewswireVapotherm and Flight Medical Announce Partnership to Bring the VentO2ux™ Ventilator to US HospitalsVapotherm, Inc. and Flight Medical Innovations Ltd. have announced a strategic partnership to distribute the VentO2ux™ ventilator in US hospitals. This collaboration expands Vapotherm's product portfolio into full-featured mechanical ventilation while allowing Flight Medical to reach more US customers with its portable ventilator technology.PR NewswireVapotherm HVT® 2.0 Earns DoD Authority to Operate Certification, Advancing Secure Respiratory Support for Military and VA HospitalsVapotherm, Inc. announced that its HVT 2.0 high velocity therapy system has received Authority to Operate (ATO) certification from the Department of Defense under the DoD's Risk Management Framework. The certification enables the system to be deployed across DoD hospitals and Veterans Affairs medical centers as a stand-alone high flow oxygen system. The certification ensures compliance with federal cybersecurity standards, provides enhanced data protection for patients, and allows faster installation with seamless network integration into military and VA healthcare systems.PharmiWeb.comHigh Flow Oxygen Therapy Devices Market to Register to US$ 1.4 Billion by 2035 Amid Decreasing Pandemic-Driven DemandThe global high flow oxygen therapy devices market was valued at US$1.7 billion in 2022 and is projected to decline to US$1.4 billion by 2031, a negative CAGR of -2.4%. The decline reflects reduced pandemic-driven demand and rising alternative therapies, with companies like Fisher & Paykel, Philips, and Vapotherm investing in next-generation solutions.PR NewswireVapotherm Announces Closing of MergerVapotherm, Inc. has closed its merger with a newly-formed entity organized and funded by an affiliate of Perceptive Advisors, LLC. The transaction involved Perceptive investing $50.0 million in new preferred equity and existing lender SLR Capital Partners converting approximately $83.0 million of term debt into preferred equity. Following the closing, Vapotherm's common stock trading was suspended on OTCQX and the company requested delisting.RopesgrayVapotherm Enters Merger Agreement to Go PrivateVapotherm, Inc. has entered into a definitive merger agreement to become a private company through an affiliate of Perceptive Advisors. The transaction involves Perceptive investing $50 million in new preferred equity and SLR Capital Partners converting approximately $81 million of term debt into equity. This strategic move allows Vapotherm to transition from public trading status while restructuring its capital base.PR NewswireVapotherm Enters Into Definitive Merger Agreement; Transaction Would Result In Company Going PrivateVapotherm, Inc. has signed a definitive merger agreement with a newly-formed entity funded by Perceptive Advisors to take the company private for $2.18 per share in cash. Concurrently, existing lender SLR Capital Partners agreed to convert approximately $81.0 million of term debt into preferred equity, while Perceptive will inject $50.0 million in new capital to strengthen Vapotherm's balance sheet. The transaction is expected to close in the second half of 2024 following stockholder approval.MarketScreenerPerceptive Discovery Fund LP, managed by Perceptive Advisors LLC entered into definitive merger agreement to acquire Vapotherm, Inc. for $15.1 million.Perceptive Discovery Fund LP, managed by Perceptive Advisors LLC, has entered into a definitive merger agreement to acquire Vapotherm, Inc. for $15.1 million. This acquisition highlights Perceptive Discovery's strategic move into advanced respiratory technology, particularly in supporting patients with severe respiratory issues. The deal reflects the growing interest in innovative healthcare solutions for respiratory care.PR NewswireVapotherm Reports First Quarter 2024 Financial ResultsVapotherm, Inc. reported first quarter 2024 net revenue of $19.1 million, a 7.9% increase year-over-year driven primarily by higher disposables sales in the United States. The company significantly improved its gross margin to 50.5% from 35.0% and reduced GAAP operating expenses by $4.6 million through its Path to Profitability initiatives, though it still posted a net loss of $14.8 million. The company is preparing for next year's launch of its Access365 home ventilation solution while its unrestricted cash position declined to $3.3 million from $9.7 million at year-end 2023.